Zacks upgraded Nashville, Tenn.-based Surgery Partners shares from a "hold" to a "buy" rating, according to Petro Global News.
Here are four things to know:
1. Zacks' price target on Surgery Partners shares totals $21.
2. On March 10, 2017, Stifel Nicolaus lowered the company's rating from a "buy" to a "hold."
3. Surgery Partners has a one-year low of $11.76 and one-year high of $22.85.
4. The market cap is $967.64 million.